Results 1 to 10 of about 2,068 (144)

Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG1 antibodies [PDF]

open access: yesmAbs
Bispecific antibodies, including bispecific IgG, are emerging as an important new class of antibody therapeutics. As a result, we, as well as others, have developed engineering strategies designed to facilitate the efficient production of bispecific IgG ...
Wen-Ting K. Tsai   +15 more
doaj   +6 more sources

Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system [PDF]

open access: yesMAbs, 2015
Bispecific antibodies have emerged in recent years as a promising field of research for therapies in oncology, inflammable diseases, and infectious diseases. Their capability of dual target recognition allows for novel therapeutic hypothesis to be tested, where traditional mono-specific antibodies would lack the needed mode of target engagement.
Gang Yin   +2 more
exaly   +5 more sources

Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity [PDF]

open access: yesMAbs, 2013
Knobs-into-holes is a well-validated heterodimerization technology for the third constant domain of an antibody. This technology has been used to produce a monovalent IgG for clinical development (onartuzumab) and multiple bispecific antibodies. The most advanced uses of this approach, however, have been limited to E.
Justin Scheer   +2 more
exaly   +5 more sources

Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry [PDF]

open access: yesMAbs, 2016
The quadroma antibody represents the first attempt to produce a bispecific heterodimeric IgG antibody by somatic fusion of 2 hybridoma cells each expressing monoclonal antibodies with distinctive specificities. However, because of random heavy and light chain pairing, the desired functional bispecific antibody represents only a small fraction of the ...
Christian Klein   +2 more
exaly   +5 more sources

Effect of allotypic variation of human IgG1 on the thermal stability of disulfide-linked knobs-into-holes mutants of the Fc for stable bispecific antibody design. [PDF]

open access: yesAntib Ther, 2019
AbstractBackgroundDisulfide-linked knobs-into-holes (dKiH) mutation is a well-validated antibody engineering technique to force heterodimer formation of different Fcs for efficient production of bispecific antibodies. An artificial disulfide bond is created between mutated cysteine residues in CH3 domain of human IgG1 Fc whose positions are 354 of the “
Akiba H, Satoh R, Nagata S, Tsumoto K.
europepmc   +4 more sources

Construction of bispecific antibodies by specific pairing between the heavy chain and the light chain using removable SpyCatcher/SnoopCatcher units [PDF]

open access: yesJournal of Biological Engineering
During the production of bispecific antibodies (bsAbs), nonspecific pairing results in low yields of target bsAb molecules, an issue known as the “mispairing problem.” Several antibody engineering techniques have been developed to overcome mispairing ...
Jyunna Yoshida   +7 more
doaj   +2 more sources

Physicochemical and biological characterization of a bispecific antibody in a CrossMab/KIH format that targets EGFR and VEGF-A [PDF]

open access: yesFrontiers in Immunology
IntroductionBispecific antibodies (BsAbs) are a class of antibody therapeutics engineered in various molecular formats to bind two distinct antigens and potentially mediate multiple biological effects.
Safiat Ayinde   +3 more
doaj   +2 more sources

Aglycosylated knob and hole Fc homodimers are anti-parallel [PDF]

open access: yesActa Crystallographica Section A Foundations and Advances, 2014
Bispecific antibody and antibody-like molecules are of wide interest as potential therapeutics that can recognize two distinct targets. Among the variety of ways such molecules have been engineered is by creating ""knob"" and ""hole"" heterodimerization sites in the CH3 domains of two antibody heavy chains.
Mark Ultsch   +7 more
  +14 more sources

Bispecific antibodies with Fab-arms featuring exchanged antigen-binding constant domains

open access: yesBiochemistry and Biophysics Reports, 2021
Monoclonal antibodies can acquire the property of engagement of a second antigen via fusion methods or modification of their CDR loops, but also by modification of their constant domains, such as in the mAb2 format where a set of mutated amino acid ...
Filippo Benedetti   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy